基于阈值的心脏CT心肌纤维化定量作为非缺血性扩张型心肌病预后标志物的可行性
本研究纳入43例非缺血性扩张型心肌病患者,行心脏CT与MRI,比较手动与基于阈值(2、3、4个标准差)的MDE定量方法在100 kVp、120 kVp及70 keV三组CT图像上的表现。70 keV CT的4-SD阈值与MRI一致性最高(CCC=0.803),观察者间一致性优秀(ICC=0.810);中位随访1625天,10例发生主要复合终点,以最佳MDE阈值4.3%分组的无事件生存率有显著差异(log-rank P=0.005)。
要点
- 70 keV单能CT的4-SD阈值定量MDE与MRI一致性最高,CCC=0.803,ICC=0.810。
- 以最佳MDE阈值4.3%分组,无事件生存率有显著差异(log-rank P=0.005)。
- 43例中29例(67%)可见LGE,5-SD阈值下平均LGE为4.1%±3.6%。
核心结论
- 70 keV单能CT的4-SD阈值定量MDE作为心肌纤维化标志物,其结果与MRI相当,在NIDCM患者中显示出预后价值。
研究设计与样本
- 研究纳入43例NIDCM患者(59.3±17.1岁;21例男性),行心脏CT与MRI检查;CT图像包括100 kVp、120 kVp和70 keV三组,MDE采用手动及基于2、3、4个标准差阈值的定量方法。
关键影像表现/征象
- 43例中29例(67%,29/43)可见LGE,5-SD阈值下平均LGE为4.1%±3.6%。
- 70 keV CT的4-SD阈值定量MDE与MRI的CCC=0.803,ICC=0.810。
- 该法与MRI相比偏倚最小(-0.119%),95%一致性界限范围为-4.216%至3.978%。
诊断标准与关键数值
- CT上MDE定量采用2、3、4个标准差阈值,分别在100 kVp、120 kVp和70 keV图像上计算;70 keV CT的4-SD阈值与MRI一致性最高(CCC=0.803)。
- 以最佳MDE阈值4.3%将患者分为风险亚组,两组无事件生存率有显著差异(log-rank P=0.005)。
临床应用与阅片要点
- 在70 keV单能CT图像上采用4-SD阈值定量MDE,可作为评估NIDCM心肌纤维化的方法,其结果与MRI相当。
- MDE定量值以4.3%为阈值分组时与预后相关,可供阅片时参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study investigated the feasibility and prognostic relevance of threshold-based quantification of myocardial delayed enhancement (MDE) on CT in patients with nonischemic dilated cardiomyopathy (NIDCM).
MATERIALS AND METHODS: Forty-three patients with NIDCM (59.3 ± 17.1 years; 21 male) were included in the study and underwent cardiac CT and MRI. MDE was quantified manually and with a threshold-based quantification method using cutoffs of 2, 3, and 4 standard deviations (SDs) on three sets of CT images (100 kVp, 120 kVp, and 70 keV). Interobserver agreement in MDE quantification was assessed using the intraclass correlation coefficient (ICC). Agreement between CT and MRI was evaluated using the Bland-Altman method and the concordance correlation coefficient (CCC). Patients were followed up for the subsequent occurrence of the primary composite outcome, including cardiac death, heart transplantation, heart failure hospitalization, or appropriate use of an implantable cardioverter-defibrillator. The Kaplan-Meier method was used to estimate event-free survival according to MDE levels.
RESULTS: Late gadolinium enhancement (LGE) was observed in 29 patients (67%, 29/43), and the mean LGE found with the 5-SD threshold was 4.1% ± 3.6%. The 4-SD threshold on 70-keV CT showed excellent interobserver agreement (ICC = 0.810) and the highest concordance with MRI (CCC = 0.803). This method also yielded the smallest bias with the narrowest range of 95% limits of agreement compared to MRI (bias, -0.119%; 95% limits of agreement, -4.216% to 3.978%). During a median follow-up of 1625 days (interquartile range, 712-1430 days), 10 patients (23%, 10/43) experienced the primary composite outcome. Event-free survival significantly differed between risk subgroups divided by the optimal MDE cutoff of 4.3% (log-rank P = 0.005).
CONCLUSION: The 4-SD threshold on 70-keV monochromatic CT yielded results comparable to those of MRI for quantifying MDE as a marker of myocardial fibrosis, which showed prognostic value in patients with NIDCM.
引用
- Kim NY, Im DJ, Hong YJ, et al. Feasibility of the Threshold-Based Quantification of Myocardial Fibrosis on Cardiac CT as a Prognostic Marker in Nonischemic Dilated Cardiomyopathy. Korean J Radiol. 2024. PMID: 38807335. doi:10.3348/kjr.2023.1271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。